Dr Camilla Hoyos

Dr Camilla Hoyos, NHMRC-ARC Dementia Research Fellow, The University of Sydney.

Camilla is a NHMRC-ARC Dementia Research Fellow in the School of Psychology, Charles Perkins Centre and Brain and Mind Centre at the University of Sydney. She is also an affiliate researcher in the Centre for Sleep and Chronobiology at the Woolcock Institute of Medical Research. Dr Hoyos is passionate about generating new knowledge on how sleep disorders, insufficient sleep and poorly timed sleep impact on health. Her work is determining whether reversing sleep problems with various therapies leads to reduced risk and impact of diabetes, heart disease and dementia.  Camilla currently leads various clinical trials of pharmacological (melatonin, cannabinoids) and non-pharmacological (sleep apnoea devices, digital behavioural therapies) interventions.

Forefront Group:

  • BMC Healthy Brain Ageing Research group
  • NHMRC CRE to Optimise Sleep in Brain Ageing and Neurodegeneration (CogSleep)

Affiliate Organisations

USyd, Faculty of Science, School of Psychology USyd, Charles Perkins Centre Woolcock Institute of Medical Research, Centre for Sleep and Chronobiology

Expertise:

  • Sleep Disorders
  • Sleep
  • Clinical Trials

Neurodegeneration of interest:

Sleep disorders, Ageing, cognitive impairment

Specific Skills:

  • Clinical Trial Design
  • Methodology
  • Analysis and Reporting

Projects

  • Reducing Sleep Apnea for the PrEvnetion of Dementia (Reshaped), CID- Operational Committee co-lead.
  • Targeting the heart to optimise healthy brain ageing in different at-risk populations across adulthood, CIA
  • Effect of Melatonin supplementation on brain oxidative stress and sleep in mild cognitive impairment - A Randomised-Placebo Controlled Pilot study-CIA
  • Cannabinoids and sleep: A randomised, placebo-controlled crossover pilot study of 20:1 CBD:THC for insomnia, Co-PI
  • NHMRC Centre of Research Excellence, CIF: Optimise Sleep in Brain Ageing and Neurodegeneration
  • "Local Sleep" in the Awake Brain: An Underlying Cause of Neurobehavioural Deficits in Sleep Apnea, CIE
  • Colchicine-Cog- The effects of long-term low-dose colchicine on cognition and brain health in patients with established coronary artery disease- a randomized controlled study’
  • Circadian Rhythms and Cognition: Investigating Chronotypes and Circadian Dysregulation in Mild Cognitive Impairment, CIA
  • Sleep disturbance in mci: a pilot study of a cognitive behavioural therapy digital intervention (succeed), Co-PI
  • Brain oxidative stress and cognitive function in older adults with diabetes and pre-diabetes who are ‘at risk’ for dementia- CIA

Project - The effects of long-term low-dose colchicine on cognition and brain health in patients with established coronary artery disease- a randomized controlled study

All Chief investigators and associate investigators

Hoyos CM, Naismith SL, Patel S, Duffy SL

Research Project Abstract

2019-2021

Disease area:

NA

Project - Targeting the heart to optimise healthy brain ageing in different at-risk populations across adulthood

All Chief investigators and associate investigators

Hoyos CM

Research Project Abstract

2021-2025

Disease area:

Sleep Disorder, Ageing

Project - Brain oxidative stress and cognitive function in older adults with diabetes and pre-diabetes who are ‘at risk’ for dementia.

All Chief investigators and associate investigators

Hoyos CM, Naismith SN, Colagiuri S, Duffy SL.

Research Project Abstract

2017-2020

Disease area:

Ageing